[EN] TREATMENT AND DIAGNOSIS OF CANCER<br/>[FR] TRAITEMENT ET DIAGNOSTIC DU CANCER
申请人:RGENIX INC
公开号:WO2016100619A2
公开(公告)日:2016-06-23
This invention features compounds that modulate the activity of liver X receptors, pharmaceutical compositions including the compounds of the invention, and methods of utilizing those compositions for modulating the activity of liver X receptors for the treatment of cancer.